Biosimilars 2021 Year in Review
Fish & Richardson Trademark & Copyright Thoughts
JANUARY 11, 2022
Semglee ® (Mylan (Viatris) / Biocon). Fulphila ® (Mylan/Biocon). MYL-1402O (Mylan / Biocon). Samsung Bioepis / Biogen). Lucentis ®. Roche / Genentech). ranibizumab-nuna. September 17, 2021. No earlier than June 2022. insulin glargine-yfgn. July 28, 2021. 31 months 4. August 31, 2020. Interchangeable: November 2021. June 4, 2018.
52 
Let's personalize your content